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Abstract 
The dietary flavonoid quercetin is an antioxidant that possesses anti-inflammatory and 
anticarcinogenic properties and may modulate signaling pathways. Inflammation is 
considered to play a pivotal role in carcinogenesis by triggering activation of 
transcription factors such as NF-κB, functionally dependent on cellular redox status. 
This study aims to investigate the anti-inflammatory effect of quercetin and its role on 
the NF-κB pathway, and COX-2 and MAPKs modulation in a human hepatoma cell line 
(HepG2). Quercetin alone did not modify any of the parameters analyzed but protected 
cells against activation of the NF-κB route induced by TNF-α. This inhibitory effect of 
quercetin was mediated, at least in part, by ERK, JNK and reactive oxygen species, and 
it was accompanied by reduced COX-2 levels. These observations suggest that 
quercetin may contribute as an anti-inflammatory agent in the liver and provide 
evidences about its role in the prevention of diseases associated with inflammation, 
including cancer. 
 
 
Keywords: COX-2, HepG2 cells, NF-κB signaling, MAPKs, Quercetin. 
                                                                                                        Granado-Serrano 
 
3 
3 
1. Introduction 
Consumption of fruits and vegetables has been connected to a reduced risk of chronic 
diseases, such as cancer (1), and many studies have demonstrated that one of the more 
active family of phytochemicals in these fruits and vegetables is that of polyphenols (1). 
The flavonol quercetin is the most common plant-derived flavonoid in the diet (1), and 
it is extensively metabolized in the small intestine and in the liver (2). Quercetin 
possesses antioxidant properties (3), potential anti-proliferative and anticarcinogenic 
activities (4-6), and it is a potent anti-inflammatory agent (7-10). 
A causal relationship between inflammation and cancer has long been suspected (11). 
Epidemiological studies suggest that major risk factors for hepatocelullar carcinoma are 
persistent infection with hepatitis B and C virus and exposure to genotoxic and 
cytotoxic chemicals, all of which cause inflammation (12). It has been described that in 
this inflammatory process, the vast majority of cellular events require the nuclear factor-
kappa B (NF-κB) activation (11, 12). However, the molecular mechanisms linking 
chronic inflammation and cancer are not well known yet. 
NF-κB is a transcription factor that regulates inflammation, immunity, apoptosis, cell 
proliferation and differentiation after binding to DNA and activating gene transcription 
(13, 14). NF-κB is activated by a wide variety of inflammatory stimuli, including tumor 
necrosis factor α (TNF), interleukin-1 (IL-1), lipopolysaccharide (LPS) or H2O2. The 
cytokine TNF plays an important role in initiating and perpetuating NF-κB signaling 
and chronic inflammation (15). Stimulation of cells with pro-inflammatory agents 
causes the activation of inhibitor of κB (IκB) kinase (IKK), which in turn 
phosphorylates and degrades IκBα and leads to NF-κB translocation to the nucleus and 
binding to a specific DNA consensus sequence; all this results in the transcriptional 
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activation of NF-κB regulated genes involved in inflammation such as cyclooxygenase-
2 (COX-2) (13). 
COX-2 promoter is known to contain a NF-κB binding site, essential for the induction 
of this inflammatory enzyme that is activated in response to TNF (15). COX-2 catalyses 
the production of inflammatory mediators such as prostagladins and is persistently 
overexpressed in chronic liver inflammation and cirrhosis, as well as in experimental 
and human hepatocellular carcinoma (16, 17). COX-2 could be locally induced by pro-
inflammatory mitogens, cytokines and growth factors during inflammation and 
carcinogenesis, suggesting that COX-2 may play a role in hepatocarcinogenesis (17). 
In addition, the induction of NF-κB activity by TNF can also be modulated by MAPKs, 
such as JNK, ERK, p38 and the PI3K/AKT pathway (15). Activation of these molecular 
routes depends in most cases on the production of reactive oxygen species (ROS) (18). 
In this regard, increased production of ROS is a common feature in both cancer and 
inflammation and it can stimulate the NF-κB pathway (18). 
Recently, several studies have demonstrated that quercetin and other polyphenols 
suppress a number of key elements in cellular signal transduction pathways resulting in 
the inhibition of pro-inflammatory mediators (7, 9, 10, 19-21). Thus, quercetin and 
other phenolic compounds show anti-inflammatory effects through the down-regulation 
of the NF-κB pathway (7-10, 19-22), although no effects on NF-κB activation has been 
occasionally reported (23). However, the detailed molecular mechanism of action of this 
phenolic compound to modulate the NF-κB pathway and COX-2 expression in liver 
cells during an inflammatory process is still poorly understood. 
The present study is aimed to test whether the anti-inflammatory effect of quercetin is 
mediated through the modulation of the NF-κB pathway, COX-2 and members of 
MAPKs family. Results demonstrate that quercetin is a potent inhibitor of the TNF-
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stimulated NF-κB pathway, which is mediated at least in part by the inhibition of ERK- 
and JNK-MAPKs. Quercetin also inhibits TNF-induced inflammatory enzyme COX-2 
and intracellular ROS generation. 
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2. Materials and methods 
Materials and chemicals 
Quercetin, 6-diamidino-2-phenylindole (DAPI), gentamicin, penicillin G and 
streptomycin were purchased from Sigma Chemical (Madrid, Spain). Anti-ERK1/2 and 
anti-phospho-ERK1/2 recognizing phosphorylated Thr202/Thy204 of ERK1/2, anti- 
JNK1/2 and antiphospho-JNK1/2 recognizing phosphorylated Thr183/Tyr185 of 
JNK1/2 and anti-β-actin were obtained from Cell Signaling Technology (9101, 9102, 
9251, 9252 and 4697, respectively Izasa, Madrid, Spain). Anti-NF-B p65 (sc-7151 and 
sc-372), anti-IKKα (sc-7218 and sc-7607), anti-IκB (sc-371), anti-phospho-Ser32-
IκB (sc-21869-R), anti-PARP (sc-7150) and anti-GRB2 (sc-255) were purchased from 
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Alexa Fluor 594 goat anti-
rabbit IgG (H+L) (A11012) and Vectashield were obtained from Molecular Probes 
(Invitrogen, Barcelona, Spain) and Vector Laboratories, Inc. (Atom, Barcelona, Spain), 
respectively. Recombinant murine TNF-alpha was from PreproTech (Tebu-bio, Madrid, 
Spain). Materials and chemicals for electrophoresis were from BioRad (BioRad 
Laboratories S.A., Madrid, Spain). Cell culture dishes and cell culture medium were 
from Falcon (Cajal, Madrid, Spain) and Lonza (Lonza, Madrid, Spain), respectively.  
 
Cell culture and quercetin treatment 
Human hepatoma HepG2 cells were grown in Dulbecco's Modified Eagle's Medium 
(DMEM) F-12 medium, supplemented with 2.5% fetal bovine serum (FBS) and 
antibiotics (50 mg/L gentamicin, 50 mg/L penicillin and 50 mg/L streptomycin). Cells 
were maintained at 37ºC in a humidified atmosphere of 5% CO2. 
Cells were changed to serum-free medium 24 h before the assay in order to avoid the 
influence of the growth factors contained in the FBS on the results. To study the effects 
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of the flavonoid, cells were treated with different concentrations of quercetin (0.1, 0.5, 
1, 5 and 10 M) and then harvested at 4 h.  
To study the effects of TNF, HepG2 cells were incubated with TNF (6 ng/mL) and 
harvested at different times (15, 30, 45 and 60 min). Additionally, in some cases after 
quercetin treatment cells were stimulated with TNF (6 ng/mL) for 30 min. 
 
Preparation of total cell lysates 
To detect ERK1/2, phospho-ERK1/2, JNK and phospho-JNK, cells were lysed at 4ºC in 
a buffer containing 25 mM N-2-hydroxyethylpiperazine-N´-2-ethanesulfonic acid 
(HEPES) (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM ethylendiaminetetraacetic acid 
(EDTA), 0.5 mM dithiothreitol (DTT), 0.1% Triton X-100, 200 mM β-
glycerolphosphate, 0.1 mM Na3VO4, 2 μg/mL leupeptin and 1 mM 
phenylmethylsulfonyl fluoride (PMSF). The supernatants were collected, assayed for 
protein concentration by using the Bio-Rad (Madrid, Spain) protein assay kit according 
to the manufacture´s specifications, aliquoted and stored at -80ºC until use for Western 
blot analyses. 
 
Preparation of nuclear and cytosolic extracts 
Cells were resuspended at 4°C in 10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 
0.5 mM DTT, 0.2 mM PMSF (buffer A), allowed to swell on ice for 10 min, and then 
vortexed for 10 s. Samples were centrifuged at 10.000g for 2 min and the supernatant 
containing the cytosolic fraction was stored at -80°C. The pellet was resuspended in 
cold buffer B (20 mM HEPES pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 
0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 2.5 μg/mL leupeptin, 2.5 μg/mL 
aprotinin) and incubated on ice for 20 min for high salt extraction. Cellular debris was 
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removed by centrifugation at 13.000g for 10 min at 4°C, and the supernatant fraction 
containing nuclear protein extract was stored at -80°C. Cytosolic and nuclear proteins 
were measured using the protein reagent following the recommendations of the 
supplier, aliquoted and stored at -80ºC until used for Western blot and ELISA analyses. 
 
Western blot analysis 
Equal amounts of proteins (100 μg) were separated by SDS-polyacrylamide gel 
electrophoresis and transferred to polyvinylidene difluoride (PVDF) filters (Protein 
Sequencing Membrane, Bio-Rad, Madrid, Spain). Membranes were probed with the 
corresponding primary antibody followed by incubation with peroxide-conjugated anti-
rabbit immunoglobulin (GE Healthcare, Madrid, Spain). Blots were developed with the 
ECL system (GE Healthcare, Madrid, Spain). Equal loading of Western blot was 
ensured by β-actin and bands were quantified using a scanner and accompanying 
software. 
 
Measurement of the NF-κB DNA binding activity 
The DNA binding of NF-κB was measured with a colorimetric non-radioactive NF-κB 
Transcription Factor ELISA Assay (Active Motif, Rixensart, Belgium) according to the 
manufacturer’s instructions. Briefly, nuclear extracts were incubated in the 
oligonucleotide-coated wells. Then, wells were washed and incubated with the antibody 
against NF-κB (p65). Addition of the secondary antibody conjugated to horseradish 
peroxidase provided a colorimetric readout. The absorbance of each well was measured 
using a microplate reader at 450nm (Bio-Tek, Winooski, VT, USA). 
 
Immunofluorescence microscopy 
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Immunofluorescence assay was performed as previously described (24). Briefly, HepG2 
cells were seeded (25.000 cells/well) on glass coverslips with DMEM F-12 
supplemented with FBS for 24 h and changed to serum-free medium 24 h before the 
assay. After incubation with quercetin and/or TNF for the indicated times, cells were 
washed with PBS at room temperature and then fixed with 3.7% paraformaldehyde for 
10 min at room temperature. Cells were rinsed with PBS, permeabilized with ice-cold 
acetone and subsequently blocked with 1% BSA. Cells were incubated with the 
corresponding primary antibody and then incubated with the anti-rabbit Alexa Fluor-
594 conjugated secondary antibody. Nuclei were visualized by using DAPI staining. 
The coverslips were mounted in Vectashield and images were taken with a Zeiss 
Axiovert 200M immunofluorescence microscope (Carl Zeiss Microimaging GmbH, 
Munich, Germany) at 63x magnification. AxioVisionRel 4.6 software was used for 
images analysis. 
 
Cell viability assay 
Cell viability was determined using the crystal violet assay (5). HepG2 cells were 
seeded at low density (10
4
 cells per well) in 96-well plates, grown for 20 h, treated with 
the different concentrations of quercetin for 4 h and/or TNF (6 ng/mL, 0-60 min), and 
then incubated with crystal violet (0.2% in ethanol) for 20 min. Plates were rinsed with 
water, allowed to dry, and 1% sodium dodecylsulfate added. The absorbance of each 
well was measured using a microplate reader at 570 nm. 
 
Cell proliferation assay (5-bromo-2’-deoxyuridine assay, BrdU) 
A colorimetric immunoassay (ELISA) was used for the quantification of cell 
proliferation. This method is based on the measurement of BrdU incorporation into 
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genomic DNA during DNA synthesis of proliferating cells. HepG2 cells were seeded 
(10
4
 cells per well) in 96-well plates, grown 20 h and labeled by the addition of BrdU 
for 4 h. Then the anti-BrdU antibody was added and the immune complexes were 
detected by the subsequent substrate (tetramethylbenzidine) reaction and quantified by 
measuring the absorbance at 620 nm in a microplate ELISA reader. 
 
Determination of reactive oxygen species (ROS) 
Cellular oxidative stress was quantified by the dichlorofluorescin (DCFH) assay using a 
microplate reader (4). Briefly, 5 M DCFH was added to the wells (2x105 cells per 
well) for 30 min at 37ºC. Then cells were washed twice with serum-free medium and 
multiwell plates were immediately measured at the fixed times in a fluorescent 
microplate reader (Bio-Tek, Winooski, VT) at excitation wavelength of 485 nm and 
emission wavelength of 530 nm. After being oxidized by intracellular oxidants, DCFH 
becomes dichlorofluorescein (DCF) and emits fluorescence. By quantifying 
fluorescence, a fair estimation of the overall oxygen species generated under the 
different conditions was obtained. 
 
Statistics 
Prior to statistical analysis, data were tested for homogeneity of variances by the test of 
Levene; for multiple comparisons, one-way ANOVA was followed by the Bonferroni 
test when variances were homogeneous or by the Tamhane test when variances were not 
homogeneous. P<0.05 was considered significant. A SPSS version 17.0 program was 
used. 
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3. Results 
To establish a model for the study of the effect of quercetin on the NF-κB pathway in 
HepG2 cells, we first checked the direct effect on the NF-κB pathway after 4 h 
treatment of cells with the flavonoid. Later, we established the time-point for further 
studies on the effect of quercetin on the NF-κB pathway to study the effect of TNF (6 
ng/mL) stimulating NF-κB in HepG2 cells at different times. 
 
Quercetin does not affect the NF-κB pathway 
To assess whether quercetin alone affects the NF-κB pathway, the effect of the 
flavonoid on p-IκB, IκB, IKK and NF-κB protein levels were evaluated after 4 h of 
incubation with different concentrations of the polyphenol. As shown in Figures 1A and 
1B, quercetin did not modify any of the mentioned protein levels and it did not affect 
the translocation of NF-кB, as the nuclear and cytosolic levels of this transcription 
factor remain unchanged after the flavonoid incubation. Additionally, it should be 
mentioned that no cytotoxicity and no effect on cell proliferation were observed in 
quercetin-treated cells at 24 h with any of the flavonoid concentrations tested (data not 
shown). 
 
TNF induces NF-κB and IKK activation 
TNF is one of the most potent activators of NF-κB, but the mechanism of activation of 
NF-κB is not fully established. Thus, the effect of TNF (6 ng/mL) through time to 
stimulate NF-κB in HepG2 cells was analyzed. TNF early activated NF-κB (15-30 min), 
as shown by the remarkable enhancement in the relative amount of nuclear versus 
cytosolic NF-кB levels, followed by a decrease to control levels at 60 min (Figures 2A-
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2C). Therefore, 30 min time, which showed the highest activation of NF-κB was 
selected as standard treatment to activate NF-κB in HepG2 cells. 
Since TNF induces NF-κB activation, the regulation of upstream members of the NF-κB 
signaling pathway was next investigated. Similar to the activation profile of NF-κB, 
TNF induced an increase in the nuclear/cytosolic IKK ratio, which was maximum after 
30 min of incubation, later recovering control levels (60 min) (Figures 2A and 2B). 
The concentration of TNF used and the time of exposure had no effect on the viability 
of the cells (data not shown). 
 
Quercetin inhibits TNF-induced NF-κB and IKK activation 
The effect of quercetin on TNF-induced NF-κB activation was studied in HepG2 cells 
preincubated for 4 h with different concentrations of quercetin and then treated with 
TNF (6 ng/mL) for 30 min. Results in Figures 3A and 3B shows that the flavonoid 
abolished the TNF-dependent activation of NF-κB. 
To further confirm the effect of quercetin pretreatment on the suppression of nuclear 
translocation of NF-κB, an immunocytochemistry assay was performed. As shown in 
Figure 3C, after 30 min of incubation TNF clearly induced nuclear translocation of p65-
NF-κB, whereas pretreatment with quercetin suppressed its translocation to the nucleus, 
in agreement with the Western blot results (Figures 3A and 3B). 
Correspondingly to NF-κB, quercetin incubation suppressed the TNF-induced IKK 
levels, resulting in the inhibition of IKK translocation in a concentration-dependent 
manner (Figures 3A and 3B). 
The concentration of quercetin and TNF used and the time of exposure had no effect on 
the viability of the cells (data not shown). 
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Quercetin inhibits NF-κB DNA binding activity 
To determine whether quercetin blocks NF-κB activation by interfering with its binding 
to DNA, nuclear extracts were prepared from quercetin-pretreated cells, incubated with 
6 ng/mL TNF for 30 min and then examined for their ability to bind to DNA. Figure 3D 
shows that TNF treatment highly increased the binding of NF-κB to the DNA, and that 
quercetin pretreatment caused a dose-dependent reduction on DNA binding of this 
transcription factor. 
 
Quercetin inhibits TNF-dependent IB phosphorylation 
IB is phosphorylated by IKK (13), and we have demonstrated that quercetin 
diminished TNF-induced IKK levels in a dose-dependent manner, then the effect of 
quercetin pretreatment and later incubation with TNF (6 ng/mL) on IB 
phosphorylation was determined. TNF induced IB phosphorylation, showed maximum 
levels after 30 min of incubation, followed by a decrease to values comparable to 
untreated cells at 45 and 60 min (Figures 4A and 4B). 
Quercetin pretreatment suppressed the TNF-induced IB phosphorylation, recovering 
control values after 10 M quercetin incubation (Figures 4C and 4D). 
 
Quercetin inhibits TNF-dependent IB degradation 
Translocation of NF-κB to the nucleus is preceded by the proteolytic degradation of IB 
(13). Thus, TNF incubation caused a rapid reduction of IB levels (15-30 min) to later 
return to control levels after 45 min of treatment onwards (Figures 4A and 4B). 
To determine whether quercetin inhibition of TNF-induced NF-κB activation was due to 
inhibition of IB degradation, cells were pretreated with the flavonoid for 4 h, then 
exposed to TNF for 30 min and IB levels analyzed. Quercetin induced a restoration in 
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IB levels, although IB control values were not totally reached even with the highest 
concentration of quercetin (10 M) (Figures 4C and 4D). 
 
Quercetin attenuates ROS overproduction induced by TNF 
NF-κB activation is also related to ROS production (18). Accordingly, HepG2 cells 
were treated with different quercetin concentrations for 4 h and then exposed to TNF (6 
ng/mL) for 30 min. As shown in Figure 5, cells incubated with TNF showed an 
increased ROS production, whereas DCF fluorescence intensity significantly dropped in 
the presence of 0.5-10 M quercetin, reaching values even lower that those of untreated 
control cells. 
 
Quercetin represses TNF-induced COX-2 levels 
A number of studies have demonstrated that quercetin and other polyphenols show anti-
inflammatory effects through downregulation of COX-2 (7, 22). It is also known that 
this inducible enzyme contributes to the pathogenesis of various inflammatory diseases 
and tumor growth (16, 17). Therefore, it was considered relevant to assess whether 
quercetin alone affects COX-2 protein and the effect of the flavonoid on its levels was 
evaluated after 4 h of incubation with different concentrations of the polyphenol. As 
shown in Figures 6A and 6B, 5-10 M quercetin diminished COX-2 protein levels. 
COX-2 is activated in response to TNF by NF-κB (15). Thus, it was investigated 
whether quercetin pretreatment can suppress COX-2 protein levels. As shown in 
Figures 6C and 6D, TNF induced COX-2 values in HepG2 cells and quercetin 
pretreatment partly suppressed them, showing comparable values to untreated cells with 
10 M quercetin. 
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Quercetin inhibits TNF-induced activation of JNK and ERK 
ERK-MAPK and JNK-MAPK play an important role in cell survival/proliferation as 
well as in apoptosis, and can be modulated by polyphenols (1). To investigate whether 
quercetin treatment in HepG2 cells was able to activate key proteins related to cellular 
survival/proliferation or apoptosis, ERK and JNK were analyzed. Figures 7A and 7B 
illustrate that a 4 h treatment with quercetin did not show a significant effect on the 
levels phosphorylated ERK and JNK in HepG2 cells. Likewise, there was no difference 
in the total levels of ERK and JNK. These results, together with the lack of effect on 
cell damage and on cell proliferation reported above, suggest that 4 h of treatment with 
quercetin has neither a prominent cytotoxic effect nor a proliferative/survival action in 
HepG2 cells. 
TNF is a potent activator of JNK and ERK, which have been implicated in the 
activation of NF-кB (25). Therefore, the effect of quercetin on TNF-induced activation 
of these MAPKs was investigated. HepG2 cells were pretreated for 4 h with quercetin 
and then stimulated with TNF (6 ng/mL) for 30 min. 
TNF activated JNK phosphorylation by about 7 fold, an activation that was gradually 
reverted with increasing concentrations of quercetin. Quercetin (10 M) completely 
inhibited the enhancement in the p-JNK levels induced by TNF (Figures 7C and 7D). 
Quercetin also inhibited the TNF-induced activation of ERK in a dose-dependent 
manner to reach control values at 5 and 10 M quercetin (Figures 7C and 7D). Total 
ERK and JNK protein levels did not change during Q plus TNF exposure. 
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4. Discussion 
Quercetin is commonly consumed in the diet and a large body of evidence indicates that 
it possesses a variety of biological activities including antioxidant (3), antiproliferative 
(4-6), and anti-inflammatory (7, 10). The apoptotic and anti-inflammatory effects of 
quercetin and the gene expression pattern associated to these processes could suggest 
that quercetin likely suppresses NF-κB activation. However no studies have been 
conducted on the cellular mechanisms involved in the quercetin-mediated regulation of 
pro-inflammatory mediators in TNF-stimulated hepatic cells. 
In this study a model of inflammation in HepG2 cells for NF-κB activation induced by 
TNF has been established and the effect of quercetin on NF-κB pathway, ROS 
production, MAPKs (ERK and JNK) and COX-2 modulation has been tested. Here 
evidence is provided for the potential role of quercetin in reducing TNF-induced 
inflammation through downregulation of NF-κB, ERK, JNK, COX-2 and ROS 
generation. 
Inappropriate modulation of NF-κB, which is a major molecular coordinator of 
inflammatory responses (11-14), has been associated with various pathological 
conditions including cancer, and constitutes one of the key pathways affecting the 
development of many chronic diseases (12-14). We have found that TNF rapidly causes 
phosphorylation and degradation of IκB, as well as IKK and NF-κB activation, in 
agreement with previous studies (15), whereas quercetin alone, at the doses used in this 
work, does not affect the NF-κB pathway. However, studies concerning the relationship 
between flavonoids and the NF-κB pathway are discrepant. Thus, it has been reported 
that dietary quercetin does not reduce NF-κB activation in the renal cortex of rats with 
established chronic glomerular disease (23) and that quercetin does not suppress DNA 
binding activation of NF-κB in LPS-stimulated macrophages (26). It has also been 
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described that quercetin fails to inhibit TNF-α-induced NF-κB translocation in 
osteoblasts (27), and that apple, cherry and blackcurrant (containing quercetin) 
increased LPS-induced NF-κB activation in transgenic NF-κB-luciferase mice (28). On 
the contrary, our results demonstrate that quercetin is a potent inhibitor of NF-κB 
activation induced by the pro-inflammatory agent TNF. Thus, in TNF-stimulated 
HepG2 cells quercetin decreased IκBα degradation and repressed upregulation of IKK, 
and these effects on the IKK/IκB cascade would in turn contribute to the inhibition of 
the NF-κB activation. This is in agreement with reports showing that quercetin prevents 
LPS-IκB phosphorylation in bone marrow derived macrophages (29), that quercetin 
inhibits NF-κB activation induced by different pro-inflammatory agents, including TNF, 
in hepatic (9, 19), and epithelial cells (10), as well as in macrophages (8). Similarly, 
quercetin reduces polyp number and size distribution in the Apc
Min/+
 mouse by reducing 
inflammation, as diminished macrophage infiltration (30). Quercetin also significantly 
decreases the phosphorylation of IκBα/β in TNF-stimulated peripheral blood 
mononuclear cells (31). 
Many reports have demonstrated the cytotoxicity of quercetin as a pro-apoptotic agent 
(4-6). To exclude the possibility that quercetin may affect the viability and/or 
proliferation of hepatic cells, the toxicity of the flavonoid after 24 h treatment was 
investigated. In full agreement with previous results, quercetin was not toxic to human 
HepG2 cells at concentrations  10 µM (4, 19, 32). Similarly, cell viability was neither 
affected by 30 min-TNF incubation alone or in combination with the flavonoid. 
ROS are proposed to be involved in NF-κB activation (18). Likewise, many 
antioxidants exert an inhibitory action on NF-κB activation through the modulation of 
the intracellular redox status (9, 33). In line with this, TNF-induced ROS generation 
could be related to the stimulation of the NF-κB pathway (18), whereas inhibition of the 
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NF-κB signaling could be associated, at least partly, to the significant free radical 
scavenger properties of quercetin. Similarly, quercetin attenuates the NF-κB activation 
induced by IL-1, which in turn stimulates ROS production (9). Thus, these results 
suggest the importance of intracellular ROS levels for quercetin-inhibited NF-κB 
activation in HepG2 cells. 
Regulation of COX-2 is a complex process and its pathways of induction seem to 
converge in the activation of NF-κB. Moreover, COX-2 is regulated by NF-κB and both 
proteins are involved in tumor promotion and inflammation (13, 17, 34). COX-2 is 
rarely expressed constitutively, but it is highly induced by cytokines, growth factors and 
tumor promoters (17). The present results indicate that TNF induces COX-2 protein in 
HepG2 cells, which could be related to the activation of the NF-κB pathway (34), 
whereas quercetin effectively reduced COX-2 protein levels in HepG2 cells stimulated 
with TNF. In concert, it has been reported a decreased COX-2 expression in human 
endothelial cells stimulated with a mixture of cytokines (containing TNF) previously 
treated with quercetin (35). Quercetin alone also diminished COX-2 levels and 
downregulated the NF-κB pathway in liver cells (7). Similarly, the flavonoid resveratrol 
inhibited the overexpression of COX-2 and the nuclear translocation of NF-κB in 
hepatocytes during rat hepatocarcinogenesis initiated with diethylnitrosamine (16). 
Therefore, it is possible that blockade of the NF-κB activation by quercetin contributes 
to the downregulation of COX-2 expression. Thus, the preventive effect of quercetin 
against TNF-induced changes in HepG2 cells may be due to the ability of the flavonoid 
to modulate different molecular signals and to inhibit intracellular ROS generation. 
Phosphorylation plays an important role in activating protein tyrosine kinases. Since 
accumulating evidence involves ERK and JNK pathways in NF-κB activation (34) in 
the current study, we examined the effect of quercetin on ERK- and JNK-MAPKs in the 
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absence and presence of TNF. Quercetin did not show a significant effect on the levels 
of p-JNK or p-ERK, but it inhibited ERK and JNK activation dose-dependently in TNF-
activated HepG2 cells, similarly to what has been shown for quercetin and other natural 
compounds in different cell lines stimulated with IL-1, LPS or TNF (36, 37). These 
results suggest that the inhibition of ERK and JNK, at least in part, are required for the 
inhibitory effect of quercetin on the TNF-induced upregulation of NF-κB. In this line, 
Chen et al (38) reported that vanadate treatment activated NF-κB through JNK 
activation in macrophages. Similarly, other studies showed that the specific inhibitor of 
ERK pathway blocked the nuclear activity of NF-κB (39). However, the participation of 
other signaling pathway in the modulation of the NF-κB activity cannot be ruled out 
(34, 39). 
It is noteworthy that the concentrations of quercetin used in the present study are not far 
from realistic. In human subjects, plasma concentrations in the micromolar range (0.3-
0.75 M) have been reported after consumption of 80-100 mg quercetin equivalent 
administered in the form of apples, onions, or meals rich in plant products (40). Plasma 
concentrations reached 1.5 M after 28 days of supplementation with > 1 g/day of 
quercetin (41). Moreover, levels of 10-50 M quercetin have been observed after 
ingestion of 1-2 g of quercetin (40). 
In summary, the present study demonstrates that quercetin inhibits TNF-induced COX-2 
and NF-κB pathway, which suggests that this flavonoid may act as an anti-inflammatory 
agent in the liver. The inhibitory effect of quercetin on the TNF-induced NF-κB 
activation is mediated, at least in part, by modulation of ROS generation, ERK and 
JNK. 
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Figure captions 
 
Figure 1. Effect of quercetin on phosphorylated IκBα (Ser32), total IκBα, IKK and 
(p65) NF-κB levels. (A) Bands of a representative experiment (means  SD, n=5-8). 
Equal loading of Western blots was ensured by β-actin. Means without a common letter 
differ, P<0.05. (B) Immunofluorescence images of dose-dependent status and cellular 
localization of NF-κB (p65). 6-Diamidino-2-phenylindole (DAPI) staining was used to 
visualize nuclei. These results are representative of two independent experiments. 
 
Figure 2. Effect of TNF on cytosolic (C) and nuclear (N) (p65) NF-κB and IKK levels. 
(A) Bands of a representative experiment. Anti-growth factor receptor-bound protein-2 
(GRB2) and anti-poly (ADPribose) polymerase (anti-PARP) antibodies were used as 
markers for the cytosolic and nuclear extracts, respectively. (B) Nuclear/cytosolic 
(Nuc/cyt) NF-B and nuc/cyt IKK ratios of bands determined by densitometric 
quantification. Values are means (n= 6-7), with standard deviations represented by 
vertical bars. Mean values with different letters were significantly different (P<0.05). 
(C) Immunofluorescence images of time-dependent status and cellular localization of 
NF-κB (p65). 6-Diamidino-2-phenylindole (DAPI) staining was used to visualize 
nuclei. These results are representative of two independent experiments. 
 
Figure 3. Effect of quercetin pretreatment on cytosolic (C) and nuclear (N) (p65) NF-
κB and IKK levels in TNF-stimulated cells. (A) Bands of a representative experiment. 
Anti-growth factor receptor-bound protein-2 (GRB2) and anti-poly (ADPribose) 
polymerase (anti-PARP) antibodies were used as markers for the cytosolic and nuclear 
extracts, respectively. (B) Nuclear/cytosolic (Nuc/cyt) NF-B and nuc/cyt IKK ratios of 
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bands determined by densitometric quantification (means  SD, n=6-8). Means without 
a common letter differ, P<0.05. (C) Immunofluorescence images of dose-dependent 
status and cellular localization of NF-κB (p65). 6-Diamidino-2-phenylindole (DAPI) 
staining was used to visualize nuclei. These results are representative of two 
independent experiments. (D) DNA-binding activity of NF-κB (p65) (means  SD, n= 
8). Absorbance was measured at 450 nm. Means without a common letter differ, 
P<0.05. 
 
Figure 4. (A) Time-course effect of TNF on phosphorylated IκBα (Ser32) and total 
IκBα levels. Bands of a representative experiment. (B) Percentage values of p-IκBα and 
total IκBα relative to the control condition after TNF treatment (means ± SD, n=7-9). 
(C) Effect of quercetin pretreatment on p-IκBα and total IκBα levels in TNF-stimulated 
cells. Representative blots. (D) Percentage data of p-IκBα and total IκBα relative to the 
control condition (means  SD, n=6-8) in quercetin pretreated cells and later stimulated 
with TNF (30 min). Equal loading of Western blots was ensured by β-actin. Means 
without a common letter differ, P<0.05. 
 
Figure 5. Effect of pretreatment with quercetin on intracellular ROS generation induced 
by TNF. HepG2 cultures were treated with the noted concentrations of quercetin for 4 h, 
then the cultures were washed twice and TNF (6 ng/mL) was added to all cells except 
controls for 30 min, and intracellular ROS production was evaluated and expressed as 
fluorescence units. Values are means  SD of 10-12 different samples per condition. 
Different letters denote statistically significant differences (P<0.05). 
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Figure 6. (A) Effect of quercetin on COX-2 levels. Bands of a representative 
experiment. (B) Percentage values of COX-2 relative to the control condition (means ± 
SD, n=6-8) after quercetin treatment for 4 h. (C) Effect of quercetin pretreatment on 
COX-2 levels in TNF-stimulated cells. Representative blots. (D) Percentage data of 
COX-2 relative to the control condition (means  SD, n=7-8) in quercetin pretreated 
cells and later stimulated with TNF (30 min). Equal loading of Western blots was 
ensured by β-actin. Means without a common letter differ, P<0.05. 
 
Figure 7. (A) Effect of quercetin on phosphorylated and total JNK, phosphorylated and 
total ERK1/2 levels. Bands of a representative experiment. (B) Percentage data of p-
JNK/JNK and p-ERK/ERK ratios relative to controls (means ± SD, n=6-8) after 
quercetin treatment for 4 h. (C) Effects of quercetin pretreatment on phosphorylated and 
total JNK, phosphorylated and total ERK1/2. Cells were incubated with different 
concentrations of quercetin for 4 h followed by TNF exposure. Representative blots of 
the above proteins. (D) Percentage data p-JNK/JNK and p-ERK/ERK ratios relative to 
controls (means  SD, n=5-8). The same blots were re-probed with β-actin. Means 
without a common letter differ, P<0.05. 
                                                                                                        Granado-Serrano 
 
30 
30 
Figure 1 
 
 
p-IκB
IκB
A
ß-actin
Q           0       0.1    0.5      1        5      10      M
B
IKK
NFκB
Q 0                      0.1                0.5                   1                   5                     10     μM
NFκB
DAPI
                                                                                                        Granado-Serrano 
 
31 
31 
Figure 2 
 
 
0
5
10
15
20
0 15 30 45 60
Time (min)
N
F
k
B
 (
n
u
c
/c
y
t)
(O
p
ti
c
a
l 
d
e
n
s
it
y
)
TNF-α - +             +             +             +
0               15              30              45             60 min
N
F
k
B
 (
n
u
c
/c
y
t)
(O
p
ti
c
a
l 
d
e
n
s
it
y
)
ab
0
2
4
6
8
0 15 30 45 60
Time (min)
IK
K
 (
n
u
c
/c
y
t)
(O
p
ti
c
a
l 
d
e
n
s
it
y
)
TNF-α - +             +             +              +
0               15              30              45              60 min
IK
K
 (
n
u
c
/c
y
t)
(O
p
ti
c
a
l 
d
e
n
s
it
y
)
a
b
b
c
NFB
IKK
a
B
TNF- - +                  +                     +                    +
0                      15                30                    45                   60 min
N    C   N    C   N   C   N    C    N    C
A
TNF- - +       +       +        +
0     15     30     45      60 min
PARP
GRB2
C
NFB
DAPI
a
b
b
c
                                                                                                        Granado-Serrano 
 
32 
32 
Figure 3 
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Figure 7 
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Table 1. Effect of quercetin on cell viability and proliferation after 24h of treatment. 
Cell viability was determined either as relative percent of Crystal Violet stained control 
cells. Cell proliferation was calculated as percentage of the relative increase of BrdU 
incorporated into genomic DNA over the control values. Data represent the means (± 
SD) of 8-10 separate experiments. Means within a column without a common letter 
differ, P < 0.05 
 
Quercetin 
µM 
Cell viability 
(% of viable cells) 
Cell proliferation 
(% of controls) 
0 
0.1 
0.5 
1 
5 
10 
100.16 ± 2.05
a
 
99.39 ± 1.63
a
 
98.45 ± 1.17
a
 
97.14 ± 1.52
a
 
97.18 ± 1.57
a
 
96.70 ± 2.05
a
 
100.27 ± 6.85
a
 
91.78 ± 9.59
a
 
93.47 ± 7.86
a
 
95.89 ± 6.85
a
 
91.78 ± 8.22
a
 
93.15 ± 5.48
a
 
 
 
 
